Stockreport

The Medicines Company Presents Clinical Data Analyses for Inclisiran at 87th European Atherosclerosis Society Congress

MEDICINES  (MDCO) 
Last medicines earnings: 10/30 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: themedicinescompany.com/investors
PDF Inclisiran administration led to consistent LDL-C reductions, with no dose adjustment required regardless of renal function, in a combined an [Read more]